arrow
M

Markus Riester

Novartis
H指数:30
被引数:7,380

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2023-08-211
PRE
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
2022-06-0237
OAAI
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
2020-12-09125
OAAI
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma
2020-10-1570
OAAI
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features (vol 9, 4181, 2018)
2019-01-142
OAAI
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

尼日利亚乳腺癌的表征揭示了普遍的同源重组缺陷和侵袭性分子特征

2018-10-1671
OAAI
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
2018-10-01425
PREAI
Germline variants and somatic mutation signatures in breast cancer across populations of African and European ancestry
2018-07-010
PRE
Software for the Integration of Multiomics Experiments in Bioconductor
2017-10-3171
OAAI
Comparative analysis of the genomic landscape of breast cancers from women of African and European ancestry
2017-02-151
PRE
Genomic landscape of breast cancers from women of African ancestry across the diaspora
2016-02-150
PRE
JAK-STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
2015-03-05256
OAAI